|
|
||||||||
1 Mastitis Research Laboratory, Hill Farm Research Station, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Homer 71040
2 Pharmacia and The Upjohn Company, Kalamazoo, MI 49001
3 Pfizer Inc., Lincoln, NE 68501
Antimicrobial susceptibility testing was conducted on a variety of mastitis pathogens. The infected quarters were subsequently treated during lactation with a commercially available product containing penicillin and novobiocin that was designed for lactating cows. Cows were treated as per the recommendations of the product manufacturer, and cures were determined by the absence of bacteria in both sets of duplicate quarter milk samples that were collected at 28 d posttreatment. Comparisons were made between the susceptibility of the bacteria and the therapeutic success or failure. All isolates tested were considered to be susceptible to the penicillin and novobiocin combination. Bacteriologic cure rates for newly acquired Staphylococcus aureus intramammary infection (IMI) (<2 wk induration) at 28 d posttreatment were 70%. Cure rates for chronic Staph. aureus IMI (>4 wk duration) were much lower (35%), reaffirming previous reports of the intractable nature of chronic Staph. aureus IMI. Cure rates for subclinical IMI caused by other organisms were 90% for Streptococcus agalactiae, 91% for Streptococcus uberis, 90% for Streptococcus dysgalactiae, 77% for other Streptococcus spp., and 71% for Staphylococcus spp. other than Staph. aureus. In vitro testing was considered to be a predictor of therapy outcome for IMI caused by Staphylococcus spp., newly acquired Staph. aureus, Strep. uberis, Strep. dysgalactiae, and Strep. agalactiae, but was not considered to be a useful predictor of efficacy for chronic IMI caused by Staph. aureus.
Key Words: mastitis susceptibility testing therapy
Submitted on February 5, 1996
Accepted on June 24, 1996
This article has been cited by other articles:
![]() |
O. Salat, F. Serieys, B. Poutrel, L. Durel, and L. Goby Systemic Treatment of Subclinical Mastitis in Lactating Cows with Penethamate Hydriodide J Dairy Sci, February 1, 2008; 91(2): 632 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. U. Graber, M. G. Casey, J. Naskova, A. Steiner, and W. Schaeren Development of a Highly Sensitive and Specific Assay to Detect Staphylococcus aureus in Bovine Mastitic Milk J Dairy Sci, October 1, 2007; 90(10): 4661 - 4669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Nunes, R. Bexiga, L. M. Cavaco, and C. L. Vilela Technical Note: Antimicrobial Susceptibility of Portuguese Isolates of Staphylococcus aureus and Staphylococcus epidermidis in Subclinical Bovine Mastitis J Dairy Sci, July 1, 2007; 90(7): 3242 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Petitclerc, K. Lauzon, A. Cochu, C. Ster, M. S. Diarra, and P. Lacasse Efficacy of a Lactoferrin-Penicillin Combination to Treat {beta}-Lactam-Resistant Staphylococcus aureus Mastitis J Dairy Sci, June 1, 2007; 90(6): 2778 - 2787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gill, J. C. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and P. M. Sabour Efficacy and Pharmacokinetics of Bacteriophage Therapy in Treatment of Subclinical Staphylococcus aureus Mastitis in Lactating Dairy Cattle. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2912 - 2918. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moroni, G. Pisoni, M. Antonini, R. Villa, P. Boettcher, and S. Carli Short communication: antimicrobial drug susceptibility of Staphylococcus aureus from subclinical bovine mastitis in Italy. J Dairy Sci, August 1, 2006; 89(8): 2973 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-A. Tenhagen, G. Koster, J. Wallmann, and W. Heuwieser Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J Dairy Sci, July 1, 2006; 89(7): 2542 - 2551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roesch, V. Perreten, M. G. Doherr, W. Schaeren, M. Schallibaum, and J. W. Blum Comparison of antibiotic resistance of udder pathogens in dairy cows kept on organic and on conventional farms. J Dairy Sci, March 1, 2006; 89(3): 989 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Rabello, C. R. V. M. Souza, R. S. Duarte, R. M. M. Lopes, L. M. Teixeira, and A. C. D. Castro Characterization of Staphylococcus aureus Isolates Recovered from Bovine Mastitis in Rio de Janeiro, Brazil J Dairy Sci, September 1, 2005; 88(9): 3211 - 3219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sawant, L. M. Sordillo, and B. M. Jayarao A Survey on Antibiotic Usage in Dairy Herds in Pennsylvania J Dairy Sci, August 1, 2005; 88(8): 2991 - 2999. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pengov and S. Ceru Antimicrobial Drug Susceptibility of Staphylococcus aureus Strains Isolated from Bovine and Ovine Mammary Glands J Dairy Sci, October 1, 2003; 86(10): 3157 - 3163. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gentilini, G. Denamiel, A. Betancor, M. Rebuelto, M. R. Fermepin, and R. A. De Torres Antimicrobial Susceptibility of Coagulase-Negative Staphylococci Isolated from Bovine Mastitis in Argentina J Dairy Sci, August 1, 2002; 85(8): 1913 - 1917. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |